Samalin Investment Counsel, LLC
- SEC CIK
- 0001544366
- Latest filing
- Jul 27, 2026
HALO holding history
Halozyme Therapeutics, Inc. in every 13F filed by Samalin Investment Counsel, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HALO overviewAll 13F holders of HALOFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −10,729−100.0% | Sold out | Holders |
| Q1 2025 | 10,729 | $684.7K | 0.3% | +122+1.2% | Added | Holders |
| Q4 2024 | 10,607 | $507.2K | 0.2% | +860+8.8% | Added | Holders |
| Q3 2024 | 9,747 | $557.9K | 0.2% | −2,205−18.4% | Reduced | Holders |
| Q2 2024 | 11,952 | $625.8K | 0.3% | −540−4.3% | Reduced | Holders |
| Q1 2024 | 12,492 | $508.2K | 0.2% | +316+2.6% | Added | Holders |
| Q4 2023 | 12,176 | $450.0K | 0.2% | +1,419+13.2% | Added | Holders |
| Q3 2023 | 10,757 | $410.9K | 0.2% | +4,120+62.1% | Added | Holders |
| Q2 2023 | 6,637 | $239.4K | 0.1% | +6,637 | New | Holders |